RTW Investments ALURW Position
ActiveRTW Investments increased their position in ALLURION TECHNOLOGIES, INC. (ALURW) in Q4 2025, holding $7.2M worth of shares across 5,891,430 shares.
The position was first reported in Q3 2023 and has been tracked across 10 quarterly 13F filings.
RTW Investments ALURW Position History
| Quarter | Action | Shares | Change | Value |
|---|---|---|---|---|
| Q4 2025 | Increased | 5,891,430 | +3,348,827 | $7.2M |
| Q3 2025 | Held | 2,542,603 | — | $5.2M |
| Q2 2025 | Increased | 2,542,603 | +1,492,540 | $6.2M |
| Q1 2025 | Decreased | 1,050,063 | -1,897,488 | $3.4M |
| Q4 2024 | Decreased | 2,947,551 | -749,998 | $1.3M |
| Q3 2024 | Held | 3,697,549 | — | $2.3M |
| Q2 2024 | Increased | 3,697,549 | +239,842 | $3.7M |
| Q1 2024 | Held | 3,457,707 | — | $6.1M |
| Q4 2023 | Held | 3,457,707 | — | $12.9M |
| Q3 2023 | New | 3,457,707 | +3,457,707 | $14.9M |
Frequently Asked Questions
Does RTW Investments own ALURW?
Yes. As of Q4 2025, RTW Investments holds 5,891,430 shares of ALLURION TECHNOLOGIES, INC. (ALURW) valued at $7.2M. This data comes from their SEC 13F filing.
How many hedge funds own ALURW?
1 specialist biotech hedge fund currently holds ALURW. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did RTW Investments first buy ALURW?
RTW Investments's position in ALURW was first reported in Q3 2023. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is RTW Investments's ALURW position increasing or decreasing?
RTW Investments increased their ALURW position in the most recent quarter, adding 3,348,827 shares.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
ALURWCompany Page →
All fund holders, insider trades, catalysts, and cash runway
RTW InvestmentsPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →